Recalcitrant cutaneous sarcoidosis responding to infliximab.
Heffernan
Michael P
MP
Anadkat
Milan J
MJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008875:Middle Aged; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab